News
A blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S. Food and Drug Administration. An FDA advisory panel -- the Medical Devices Advisory Committee ...
Guardant Health, Inc., a leading precision oncology company, today announced that its Shield multi-cancer detection test has been granted Breakthrough Device designation from the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback